Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 on Cerebrospinal Fluid Biomarkers in 36 Patients With Progressive Supranuclear Palsy

Trial Profile

A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 on Cerebrospinal Fluid Biomarkers in 36 Patients With Progressive Supranuclear Palsy

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AZP 2006 (Primary)
  • Indications Progressive supranuclear palsy
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors AlzProtect
  • Most Recent Events

    • 18 Sep 2019 According to an AlzProtect media release, this study should be completed by the end of 2020 for a publication of the first results in 2021.
    • 18 Sep 2019 According to an AlzProtect media release, this study will be conducted at the hospital of La Pitie Salpetriere in Paris (AP-HP), under the direction of Professor Corvol and Lille University Hospital, in the service of Professor Defebvre.
    • 18 Sep 2019 According to an AlzProtect media release, ANSM has authorized the launch of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top